Latest News

Study Shows Discordance Between PSMA PET/CT and PSA Response in 47 Percent of Patients Treated for mCRPC
Study Shows Discordance Between PSMA PET/CT and PSA Response in 47 Percent of Patients Treated for mCRPC

October 7th 2024

PSMA PET/CT revealed progressive PCa in 31 percent of patients who demonstrated greater than a 50 percent decline in PSA level after treatment with either an androgen receptor-targeted agent or chemotherapy.

Diagnostic Imaging's Weekly Scan: September 29 — October 5
Diagnostic Imaging's Weekly Scan: September 29 — October 5

October 5th 2024

FDA Clears Automated Dosimetry with the Monte Carlo Method for Radionuclide Therapy
FDA Clears Automated Dosimetry with the Monte Carlo Method for Radionuclide Therapy

October 4th 2024

Radiology Experience, Breast Density and Screening Mammography: What New Research Reveals
Radiology Experience, Breast Density and Screening Mammography: What New Research Reveals

October 4th 2024

AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer

October 3rd 2024

Video Interviews

Latest Conference Coverage

View All
Advances in AI — June 2024
Advances in AI — June 2024

June 26th 2024

Study Examines Prognostic Value of 68Ga-PSMA-11 PET/CT for Patients at High Risk of PCa
Study Examines Prognostic Value of 68Ga-PSMA-11 PET/CT for Patients at High Risk of PCa

June 21st 2024

Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Emerging Research at SNMMI Examines 18F-Flotufolastat in Managing Primary and Recurrent Prostate Cancer

June 13th 2024

SNMMI: New Study Suggests Merits of FAPI PET/CT for Breast Cancer Staging
SNMMI: New Study Suggests Merits of FAPI PET/CT for Breast Cancer Staging

June 11th 2024

All News

© 2024 MJH Life Sciences

All rights reserved.